SREBF1 and neoplasm: SREBF1 expressing C4-2B formed robust tumor growth reaching ~1300 mm3 in 9 weeks, in contrast, Y673/951A double mutant expressing cells exhibited severely compromised tumors growth (Fig. 5b).